Tibet Cheezheng Tibetan Medicine Co., Ltd.

SZSE:002287 Stock Report

Market Cap: CN¥11.5b

Tibet Cheezheng Tibetan Medicine Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Kailie Liu

Chief executive officer

CN¥2.9m

Total compensation

CEO salary percentagen/a
CEO tenure14.2yrs
CEO ownership0.08%
Management average tenure10.7yrs
Board average tenure6.6yrs

Recent management updates

Recent updates

Tibet Cheezheng Tibetan Medicine (SZSE:002287) Strong Profits May Be Masking Some Underlying Issues

Nov 05
Tibet Cheezheng Tibetan Medicine (SZSE:002287) Strong Profits May Be Masking Some Underlying Issues

Does Tibet Cheezheng Tibetan Medicine (SZSE:002287) Have A Healthy Balance Sheet?

Oct 23
Does Tibet Cheezheng Tibetan Medicine (SZSE:002287) Have A Healthy Balance Sheet?

Benign Growth For Tibet Cheezheng Tibetan Medicine Co., Ltd. (SZSE:002287) Underpins Its Share Price

Sep 25
Benign Growth For Tibet Cheezheng Tibetan Medicine Co., Ltd. (SZSE:002287) Underpins Its Share Price

Tibet Cheezheng Tibetan Medicine Co., Ltd.'s (SZSE:002287) Prospects Need A Boost To Lift Shares

Jun 07
Tibet Cheezheng Tibetan Medicine Co., Ltd.'s (SZSE:002287) Prospects Need A Boost To Lift Shares

Tibet Cheezheng Tibetan Medicine's (SZSE:002287) Profits May Not Reveal Underlying Issues

Apr 26
Tibet Cheezheng Tibetan Medicine's (SZSE:002287) Profits May Not Reveal Underlying Issues

Tibet Cheezheng Tibetan Medicine Co., Ltd.'s (SZSE:002287) Business And Shares Still Trailing The Market

Feb 27
Tibet Cheezheng Tibetan Medicine Co., Ltd.'s (SZSE:002287) Business And Shares Still Trailing The Market

CEO

Kailie Liu (60 yo)

14.2yrs

Tenure

CN¥2,866,800

Compensation

Mr. Kailie Liu serves as the President at Tibet Cheezheng Tibetan Medicine Co.,Ltd. Mr. Liu serves as General Manager of Tibet Yutuo Tibetan Medicine Group Co., Ltd., General Manager of Beijing Qizheng Tia...


Leadership Team

NamePositionTenureCompensationOwnership
Kailie Liu
President & Non-Independent Directorno dataCN¥2.87m0.084%
CN¥ 9.7m
Xiaomei Yao
Financial Director6.3yrsCN¥755.30k0.014%
CN¥ 1.6m
Jianqin Xiao
Vice President of Operations10.8yrsCN¥1.22m0.050%
CN¥ 5.8m
Weiwu Chen
Chief Scientific Officerno dataCN¥954.40k0.025%
CN¥ 2.9m
Zhiqiang Wang
VP & Director of Administration Department10.8yrsCN¥1.04m0.034%
CN¥ 3.9m
Ping Feng
VP & Secretary of the Board of Directors10.6yrsCN¥994.40k0.034%
CN¥ 3.9m
Jun Li
Vice Presidentno dataCN¥1.47m0.036%
CN¥ 4.2m
Min Zhao
Vice Presidentno dataCN¥1.06m0.0051%
CN¥ 591.3k
Haijian Xia
Vice Presidentno dataCN¥1.50m0.015%
CN¥ 1.8m

10.7yrs

Average Tenure

54yo

Average Age

Experienced Management: 002287's management team is seasoned and experienced (10.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kailie Liu
President & Non-Independent Director14.2yrsCN¥2.87m0.084%
CN¥ 9.7m
Jufang Lei
Chairman17.2yrsCN¥735.60kno data
Yu Jia
Chairman of the Supervisory Board6.6yrsno datano data
Chunyu Li
Independent Director3.6yrsCN¥100.00kno data
Zhijian He
Non-Employee Supervisor10.8yrsno datano data
Xielong Luo
Non-Independent Director6.6yrsCN¥100.00kno data
Ouzhu Suolang
Non-Independent Director10.8yrsCN¥100.00kno data
Yurong Wang
Independent Director4yrsCN¥100.00kno data
Tenzin Wanma
Supervisor6.6yrsno datano data
Yirui Wang
Supervisor5.3yrsno datano data

6.6yrs

Average Tenure

55.5yo

Average Age

Experienced Board: 002287's board of directors are considered experienced (6.6 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 20:07
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tibet Cheezheng Tibetan Medicine Co., Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuchang LiuChangjiang Securities Co. LTD.
Fusheng CheungChina Galaxy International Securities (Hong Kong)
Shanshan LiChina Merchants Securities Co. Ltd.